24/7 Customer Support

Asia Pacific Dermal Fillers Treatment Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Asia Pacific Dermal Fillers Treatment Market- (By Material- Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Polymethyl methacrylate), Collagen Fillers, Fat Fillers and Others; By Product-Biodegradable and Non-Biodegradable; By Application- Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/ Fullness, Preorbital Treatment and Others; By End User- Specialty & Dermatology Clinics, Hospitals & Clinics and Other; and By Country) - Industry Dynamics, Market Size and Opportunity Forecast, 2030

  • Published On: 10-Jun-2022  |  Format: pdfpowerpointexcel  |  Report ID: AA0622266
    Delivery: 2 to 4 Hours

FREQUENTLY ASKED QUESTIONS

Dermal fillers are used by facial surgeons to reduce the signs of ageing, scars and wrinkles. They are significant, non-invasive alternative to surgical facelifts, which are designed to be injected into the skin to add fullness and volume.

One of the most common compounds used in dermal fillers is hyaluronic acid (HA).

Face fillers have become widely popular in India, due to its pricing, painless procedure and easy accessibility.

Asia Pacific dermal fillers treatment market is estimated to expand at a CAGR of 8.9% during the forecast period. 

The Asia Pacific dermal fillers treatment market was valued at US$ 810.3 Million in 2021.  

Adoption of hyaluronic acid fillers and other bio-fillers provides a lucrative growth trend in the Asia Pacific dermal fillers treatment market.

Factors such as increase in number of cosmetic procedures and growing influence of celebrities among young population will boost the Asia Pacific dermal fillers treatment market. 

Side effects of dermal fillers such as redness, swelling, pain, bruising and itching is a restraining factor which inhibits the growth of the market during the forecast period. 

The biodegradable segment is expected to project the highest CAGR over the forecast period in the Asia Pacific dermal fillers treatment market.

Material, Product, application and end user are the different segments of the Asia Pacific dermal fillers treatment market.

China dominated the Asia Pacific dermal filler treatment market in 2021.

The key players operating in the market include ALLERGAN (AbbVie, Inc.), Revance Therapeutics, Inc., Galderma, Sinclair Pharma, Bioplus Co., Ltd., DR. Korman, Prollenium Medical Technologies, Suneva Medical, Anika Therapeutics, Inc. and LG Chem Ltd. among others.